… For one, up to 30–50% of COVID-19 survivors experience persistent dyspnea and cough
for 2–3 months. (13,15,79−81) Chest pain, heart palpitations, and tachycardia are also …

… of persistent anosmia as a sequela of COVID‐19 infection is … of olfactory dysfunction related
to COVID‐19 remains to be … dysfunction, the method of evaluation of olfactory dysfunction is …

Background Loss of olfactory function is well recognised as a symptom of COVID‐19 infection,
and the pandemic has resulted in a large number of individuals with abnormalities in their …

… at our Neuro-Covid-19 clinic. We opened this clinic in May 2020 in response to the high
frequency of nervous system dysfunction recognized in hospitalized Covid-19 patients in China …

… the presence of persistent endothelial dysfunction among COVID-19 patients within 2 months
from swab test negativization. Females may be protected from endothelial dysfunction for …

… of COVID-19 on endothelial dysfunction, we regrouped the convalescent COVID-19 patients
by their … We found that both convalescent COVID-19 patients who recovered from moderate …

Background Post-COVID-19 syndrome (PCS) is a lingering disease with ongoing symptoms
such as fatigue and cognitive impairment resulting in a high impact on the daily life of …

… of COVID-19 and sepsis patients. Based on this finding of persistence, we also identified …
treatments targeting these persistent genes in both COVID-19 and non-COVID-19 sepsis. …

… and clinical course of coronavirus disease (COVID-19). Here, … levels in early severe COVD-19
alongside increased NK cell … coronavirus 2) activity but are functionally impaired in severe …

… function in patients affected by COVID-19 often have an early … dysfunction persistence after
recovery from COVID-19, and … from COVID-19 from at least 20 days with olfactory dysfunction …